It will: Validate the efficacy signals at larger scale, and at higher resolution Identify predictive markers of safety and tolerability Assess drug-specific differences in different applications Evaluate discontinuation and rebound risk Enable head-to-head drug comparisons as data matures This moves the program from proof-of-concept to clinically actionable stratification
These compounds are sold for research, not as approved prescription therapy, and the long-term maintenance picture after stopping mirrors what we see with every appetite agent
Individuals adhering to a vegetarian or vegan diet, those aged 50 and above, or people experiencing malabsorption issues are at a higher risk of developing a deficiency
The Premature Swallow: We've already hit this hard, but it bears repeating
In the early 1990s, a major clue for extending GLP-1 action came from an unlikely source: venomous lizards
Concerns such as pancreatitis, gallbladder disease, and thyroid-related risks are uncommon but require clinical awareness